Our previous in vitro study revealed that expression of BTG2 is related to neoplasia of human prostate carcinoma cells and forced-overexpression of BTG2 in prostate carcinoma PC-3 cells attenuated cell proliferation [7]. Here, BTG2 is linked to neoplasm.